These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 4039221)

  • 1. Differential response of cultured human normal and tumor cells to trace element-induced resistance to the alkylating agent melphalan.
    Tobey RA; Tesmer JG
    Cancer Res; 1985 Jun; 45(6):2567-71. PubMed ID: 4039221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc-induced reduction in melphalan cytotoxicity: heterogeneity of response of cloned human tumor cells.
    Tobey RA; Tesmer JG; Shackelford ME
    J Cell Physiol; 1987 May; 131(2):235-9. PubMed ID: 3584249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc-induced resistance to alkylating agent toxicity.
    Tobey RA; Enger MD; Griffith JK; Hildebrand CE
    Cancer Res; 1982 Aug; 42(8):2980-4. PubMed ID: 7093947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible protective proteins: a potentially novel approach to chemotherapy.
    Tobey RA; Enger MD; Griffith JK; Hildebrand CE
    Ann N Y Acad Sci; 1982 Dec; 397():256-71. PubMed ID: 6961846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
    Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
    Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB; Zhang Y; Frenkel GD
    Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
    Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of human ovarian tumor xenografts with selenite prevents the melphalan-induced development of drug resistance.
    Caffrey PB; Frenkel GD
    Anticancer Res; 1998; 18(4C):3017-20. PubMed ID: 9713502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
    Mulcahy RT; Untawale S; Gipp JJ
    Mol Pharmacol; 1994 Nov; 46(5):909-14. PubMed ID: 7969079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents.
    Bramson J; Panasci LC
    Cancer Res; 1993 Jul; 53(14):3237-40. PubMed ID: 8324733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between sensitivity of tumor cells to chemotherapeutic agent in vivo and in vitro: experiment with mouse lymphoma cells].
    Li CG; Li ML; Shu XH; Jia YJ; Liu YJ; Li M
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1576-8. PubMed ID: 17785116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced resistance to alkylating agent toxicity obtainable by pretreatment with combinations of trace elements.
    Tobey RA; Seagrave J; Hildebrand CE
    Biol Trace Elem Res; 1983 Dec; 5(6):423-31. PubMed ID: 24263664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and characterization of Chinese hamster ovary cell mutants resistant to melphalan (L-phenylalanine mustard).
    Elliott EM; Ling V
    Cancer Res; 1981 Feb; 41(2):393-400. PubMed ID: 7448783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of trace elements in cadmium chloride uptake in hepatoma cell lines.
    Fotakis G; Timbrell JA
    Toxicol Lett; 2006 Jul; 164(2):97-103. PubMed ID: 16406389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells.
    Ortega R; Moretto P; Fajac A; Benard J; Llabador Y; Simonoff M
    Cell Mol Biol (Noisy-le-grand); 1996 Feb; 42(1):77-88. PubMed ID: 8833669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.